Non-Biological Complex Drugs

The Science and the Regulatory Landscape

Nonfiction, Health & Well Being, Medical, Specialties, Pharmacy, Science & Nature, Technology, Engineering, Chemical & Biochemical
Cover of the book Non-Biological Complex Drugs by , Springer International Publishing
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783319162416
Publisher: Springer International Publishing Publication: June 24, 2015
Imprint: Springer Language: English
Author:
ISBN: 9783319162416
Publisher: Springer International Publishing
Publication: June 24, 2015
Imprint: Springer
Language: English

The rise of bio- and nano-technology in the last decades has led to the emergence of a new and unique type of medicine known as non-biological complex drugs (NBCDs). This book illustrates the challenges associated with NBCD development, as well as the complexity of assessing the effects of manufacturing changes on innovator and follow-on batches of NBCDs. It also touches upon proven marketing authorization requirements for biosimilars that could be effective in evaluating follow-on NBCDs, including a demonstration of control over the manufacturing process and a need for detailed physico-chemical characterization and (pre)clinical tests.

This book is meant to be used for years to come as a standard reference work for the development of NBCDs. Moreover, this book aims to stimulate discussions and further our thinking to ensure that decisions regarding the approval of complex drugs are made with relevant scientific data on the table.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

The rise of bio- and nano-technology in the last decades has led to the emergence of a new and unique type of medicine known as non-biological complex drugs (NBCDs). This book illustrates the challenges associated with NBCD development, as well as the complexity of assessing the effects of manufacturing changes on innovator and follow-on batches of NBCDs. It also touches upon proven marketing authorization requirements for biosimilars that could be effective in evaluating follow-on NBCDs, including a demonstration of control over the manufacturing process and a need for detailed physico-chemical characterization and (pre)clinical tests.

This book is meant to be used for years to come as a standard reference work for the development of NBCDs. Moreover, this book aims to stimulate discussions and further our thinking to ensure that decisions regarding the approval of complex drugs are made with relevant scientific data on the table.

More books from Springer International Publishing

Cover of the book Environmental Software Systems. Computer Science for Environmental Protection by
Cover of the book Extremophilic Enzymatic Processing of Lignocellulosic Feedstocks to Bioenergy by
Cover of the book Polyglutamine Disorders by
Cover of the book Bridging the Innovation Gap by
Cover of the book Fibre Bragg Grating and No-Core Fibre Sensors by
Cover of the book On-Surface Synthesis II by
Cover of the book Business Ethics and Leadership from an Eastern European, Transdisciplinary Context by
Cover of the book Science Fiction and the Moral Imagination by
Cover of the book Urinary Diversion by
Cover of the book Wage and Hour Law by
Cover of the book Decision Support for Forest Management by
Cover of the book Computer Vision – ACCV 2016 Workshops by
Cover of the book Touschek Lifetime Studies and Optimization of the European Synchrotron Radiation Facility by
Cover of the book Corruption in Latin America by
Cover of the book Indicator-Based Monitoring of Regional Economic Integration by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy